M&A and equity raisings

6,065 deals since January 2025, with sources and adviser credits where available · as at 20 Nov 2026 · Venture rounds

US deals dated after 30 September 2026 are still being collected.

Deal size
Custom range

76 deals · US$54bndisclosed · Life Sciences · Clear

Columns
M&A deals and equity raisings
Date Target Vendor Acquirer Type Status Value US$m Sector Advisers
Oct 2026 Rekover Therapeutics TenmileInvex TherapeuticsAcquisitionAnnounced–Healthcare+1 Moore Australia (buy-side)
Sep 2026 Standard BioTools Mass Cytometry business Standard BioToolsElement BiosystemsAsset saleAnnounced5.5Life Sciences+1 Maynard Nexsen (buy-side)
Sep 2026 Lifecore Biomedical –Webster Equity PartnersAcquisitionAnnounced663.7Pharma Services+2 Bourne Capital Partners (sell-side)Craig-Hallum (sell-side)Ballard Spahr (sell-side)Zukerman Gore Brandeis & Crossman (sell-side)Morgan Stanley (buy-side)Goodwin (buy-side)
Sep 2026 Agilex Biolabs HealiusNovotech Health HoldingsAcquisitionAnnounced114.0Healthcare+1 UBS (sell-side)Mallesons (sell-side)
Sep 2026 ITM Isotope Technologies Munich SE –Telix PharmaceuticalsMergerAnnounced2,350.0Healthcare+1 Latham & Watkins (sell-side)Centerview Partners (sell-side)Morgan Stanley (buy-side)Sidley Austin (buy-side)Herbert Smith Freehills Kramer (buy-side)
Sep 2026 Firma Data Services Firma Clinical ResearchEverest Clinical ResearchAsset saleCompleted–Clinical Trial Services+1 Edgemont Partners (sell-side)
Sep 2026 Cellipont Bioservices ––MergerCompleted–Pharma Services+2 William Blair
Sep 2026 Prolytix EdgewaterVIONAcquisitionAnnounced–Pharma Services+1 Stout (sell-side)
Aug 2026 Precision Medicine Group BlackstoneMcKessonAcquisitionAnnounced2,250.0Clinical Trial Services+1 Debevoise & Plimpton (sell-side)Centerview Partners (sell-side)Davis Polk (buy-side)
Aug 2026 Schlafender Hase –Maguar CapitalAcquisitionCompleted–Vertical SaaS+1 Goodwin (buy-side)
Aug 2026 BWXT Medical business BWX TechnologiesNordic CapitalAsset salePending800.0Radiopharmaceuticals+2 Solomon Partners (sell-side)Stikeman Elliott (sell-side)Kirkland & Ellis (buy-side)McCarthy Tétrault (buy-side)
Aug 2026 South Australian Health and Medical Research Institute (SAHMRI) Government of South AustraliaAdelaide UniversityAcquisitionAnnounced–Healthcare+1 HWLE Lawyers (sell-side)
Aug 2026 MIMETAS –BRUKERAcquisitionCompleted–Life Sciences+1 Raymond James
Aug 2026 NovaBone Products HalmaIsto BiologicsAcquisitionCompleted60.0Medtech+1 Baird (buy-side)
Jul 2026 Avisoft Bioacoustics –Lafayette InstrumentAcquisitionCompleted–Life Sciences+2 Vedder Price (buy-side)RSM (buy-side)
Jul 2026 MYOS Corp –PetIQAcquisitionCompleted–Supplements+2 Davis Graham (sell-side)Davis Polk (buy-side)Lincoln International (buy-side)
Jul 2026 ArisGlobal Nordic CapitalDassault SystèmesAcquisitionAnnounced2,000.0Healthcare Software+2 Evercore (sell-side)Jefferies (sell-side)Kirkland & Ellis (sell-side)Sullivan & Cromwell (buy-side)
Jul 2026 BioLife Solutions –RepligenAcquisitionAnnounced1,500.0Life Sciences+1 Centerview Partners (sell-side)K&L Gates (sell-side)Goodwin (buy-side)Perella Weinberg Partners (buy-side)Goldman Sachs (buy-side)
Jul 2026 Personalis –Tempus AIAcquisitionAnnounced1,900.0Diagnostics+2 Centerview Partners (sell-side)TD Securities (sell-side)Cooley (sell-side)Morgan Stanley (buy-side)Latham & Watkins (buy-side)
Jul 2026 Life Sciences & Healthcare segment ClarivateAltarisAsset saleAnnounced600.0Healthcare Software+2 Davis Polk (sell-side)Morgan Stanley (sell-side)Hogan Lovells Cadwalader (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Kirkland & Ellis (buy-side)
Jul 2026 DCM BioServices –Surplus SolutionsAcquisitionAnnounced–Life Sciences+1 McDermott Will & Schulte (buy-side)
Jul 2026 GBA Group ArdianBridgepointAcquisitionAnnounced–Testing & Inspection+1 Latham & Watkins (buy-side)
Jul 2026 MeiraGTx Holdings –Oberland Capital ManagementStakeAnnounced–Biotech+1 Latham & Watkins (sell-side)
Jul 2026 Momentum Life Sciences –Parthenon Capital PartnersStakeCompleted–Healthcare Software+1 William Blair
Jul 2026 LaCorium Health founders of LaCorium HealthPrestige Consumer HealthcareAcquisitionCompleted–Healthcare+1 Addisons (sell-side)Pitcher Partners (buy-side)
Jul 2026 B Medical Systems AzentaThelema S.à r.l.Asset saleCompleted–Medtech+1 William Blair
Jun 2026 Bio-Techne –Merck KGaAAcquisitionPending11,300.0Life Sciences+1 Goldman Sachs (sell-side)Sidley Austin (sell-side)Joele Frank, Wilkinson Brimmer Katcher (sell-side)Guggenheim Securities (buy-side)J.P. Morgan (buy-side)Sullivan & Cromwell (buy-side)
Jun 2026 Sangamo Therapeutics capsid delivery, zinc finger, modular integrase platforms and prion disease program Sangamo TherapeuticsEli Lilly and CompanyAsset saleCompleted–Biotech+1 Raymond JamesPaul, Weiss (buy-side)
Jun 2026 Simulations Plus –Affiliates of AltarisAcquisitionAnnounced375.0Life Sciences+2 Morgan Stanley (sell-side)Procopio, Cory, Hargreaves & Savitch (sell-side)Bass, Berry & Sims (buy-side)Truist Securities (buy-side)J.P. Morgan (buy-side)Kirkland & Ellis (buy-side)Latham & Watkins (buy-side)
Jun 2026 Ignite Proteomics AditxtProposed Ignite Proteomics Inc. holding companyMergerPending150.0Life Sciences+2 Ladenburg Thalmann
Jun 2026 Aspen Pharmacare Asia Pacific business Aspen Pharmacare HoldingsBGH CapitalAcquisitionAnnounced1,632.2Healthcare+1 Allens (buy-side)
Jun 2026 Kalderos –Model NAcquisitionAnnounced–Healthcare Software+2 Kirkland & Ellis (buy-side)
Jun 2026 kneat.com –Thoma Bravo, L.P.AcquisitionPending453.6Vertical SaaS+1 Kirkland & Ellis (buy-side)
Jun 2026 Helio Health Group –WestView Capital PartnersStakeCompleted–AI+1 Latham & Watkins (buy-side)
May 2026 Ennov Group –Bregal SagemountStakeAnnounced–Healthcare Software+2 Proskauer RoseGoodwin (buy-side)
May 2026 Sutter Instrument Corp. –Lafayette InstrumentAcquisitionCompleted–Manufacturing+2 EC M&A (sell-side)Donahue Fitzgerald (sell-side)Akerman (buy-side)RSM (buy-side)
May 2026 Regenity Biosciences –CinvenStakeAnnounced–Medtech+1 Baird (sell-side)
May 2026 Beacon Hanson Wade GroupCorten CapitalAcquisitionAnnounced–Market Intelligence+2 Baird (sell-side)
May 2026 Imexpharm SK GroupLian SGP HoldingAcquisitionAnnounced–Healthcare+1 Allens (sell-side)Linklaters (sell-side)
Apr 2026 XOMA Royalty –Ligand PharmaceuticalsAcquisitionCompleted739.0Specialty finance and leasing+2 Leerink Partners (sell-side)H.C. Wainwright & Co. (sell-side)Gibson Dunn (sell-side)Stifel (buy-side)Citi (buy-side)Paul Hastings (buy-side)Collected Strategies (buy-side)
Apr 2026 Certara Regulatory and Medical Writing business CertaraVeristatAsset saleAnnounced135.0Pharma Services+1 Perella Weinberg Partners (sell-side)Troutman Pepper Locke (sell-side)Guggenheim Securities (buy-side)McDermott Will & Schulte (buy-side)
Apr 2026 EpiVax –SV Health InvestorsAcquisitionAnnounced–Pharma Services+2 Morgan Lewis (buy-side)
Apr 2026 Thermo Fisher Scientific's microbiology division Thermo Fisher ScientificAstorgAsset saleAnnounced1,075.0Diagnostics+1 Cravath, Swaine & Moore (sell-side)Perella Weinberg Partners (sell-side)Latham & Watkins (buy-side)Moelis & Company (buy-side)
Apr 2026 Accessus Health shareholders of Ecker + Ecker and Accessus HealthAthagorasAcquisitionAnnounced–Accounting, legal and consulting+2 Latham & Watkins (sell-side)
Apr 2026 TriNetX –Regeneron PharmaceuticalsStakeCompleted–Healthcare Software+2 William Blair
Apr 2026 Celerion H.I.G. Capital affiliateTHL PartnersAcquisitionAnnounced–Pharma Services+2 LazardKirkland & Ellis (buy-side)Paul, Weiss (buy-side)
Mar 2026 Stratis Group –Nexus HealthAcquisitionAnnounced–Accounting, legal and consulting+1 Clearsight Advisors (sell-side)Pillsbury Winthrop Shaw Pittman (sell-side)
Mar 2026 Biocare Medical –Agilent TechnologiesAcquisitionAnnounced950.0Diagnostics+1 Sullivan & Cromwell (buy-side)
Mar 2026 UK Biocentre –Azenta UKAcquisitionCompleted26.9Life Sciences+1 Deloitte (buy-side)Bird & Bird (buy-side)
Mar 2026 Lonza Capsules & Health Ingredients division Lonza Group AGLone Star FundsAsset saleAnnounced–Pharmaceutical Manufacturing+2 Kirkland & Ellis (buy-side)

Deals come from stock exchange announcements and filings, takeover and scheme documents, prospectuses, the advisers' own deal announcements and the press. How the data is built All countries counts every deal, wherever it is, including deals whose geography is not known.Country pages cover Australia, New Zealand and the United States. The United Kingdom, Canada, Singapore, China and India are planned.